SII

Telangana HC stays e-auction of another parcel of land in Puppalaguda

A writ petition was filed in the High Court by Narayan Das Rizwani against the TSIIC’s notification for e-auction of government lands in Puppalaguda and Khanamet for plots in survey number 301.

published on : 29th September 2021

Telangana High Court stays auction of 18-acre land in Puppalaguda 

Chief Secy, Principal Secy of Industries and Commerce, TSIIC & HMDA to file counters

published on : 25th September 2021

Confusion reigns over Covishield on UK's travel advisory as India not on eligibility list

So far it means, under the new rules from October 4, Indian travellers must take a COVID test three days before departure and book in advance for two COVID tests to be taken upon arrival in England.

published on : 22nd September 2021

Biocon and Serum Institute come together with strategic alliance to increase vaccine access for developing countries

As part of the deal, the BBL has offered 15% stake to SILS at a post money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annul for 15 years.

published on : 18th September 2021

Utilise Common Effluent Treatment Plants to clean Yamuna river: Delhi minister Satyendar Jain

The meeting focused on making a sustainable plan to clean Yamuna by reducing the amount of industrial waste coming through storm water drains.

published on : 15th September 2021

Serum Institute informs Centre it will supply around 20 crore Covishield doses in September

In a production plan submitted to the Centre in May, SII's director had communicated that the production of Covishield would be ramped up to 10 crore each in August and September, sources had said.

published on : 26th August 2021

COVID vaccine export ban 'very bad' move; son warned not to speak against it: SII's Cyrus Poonawalla

Over 150 countries are dependent on the SII for vaccines and are blaming the company for stopping the supply during a crucial period, Cyrus Poonawalla said.

published on : 13th August 2021

Serum Institute of India writes to Union Health Minister proposing reforms in drug regulatory system

Singh sought permission to use the remaining quantities of batches of Covid and non-Covid vaccines for commercial purposes which have been used in clinical trial.

published on : 21st July 2021

Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India

The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.

published on : 4th June 2021

Poonawalla thanks Biden, Jaishankar for policy change to boost vaccine production

Confident of the availability of COVID-19 vaccines in the US, the Biden administration has removed Defense Production Act priority ratings on AstraZeneca, Novavax and Sanofi vaccines.

published on : 4th June 2021

Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre 

India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- in its COVID-19 immunisation programme.

published on : 30th May 2021

Vaccine mix-up: Probe launched after 20 UP villagers get wrong second dose of jabs

The incident has been reported from the primary health centre in Barhni where people from Audahi Kala and another village received Covaxin shots on May 14.

published on : 26th May 2021

Serum Institute disassociates itself from its executive's remarks on Covid vaccination drive 

Prakash Kumar Singh, Director of Government and Regulatory Affairs at the SII clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company.

published on : 23rd May 2021

UK-India trade deal includes COVID vaccine investment

The British government is seeking to increase trade with countries outside the European Union following the U.K.'s departure from the bloc.

published on : 4th May 2021

Serum Institute CEO Adar Poonawalla to invest over USD 300 million in UK, may make inoculations

The British Prime Minister's office said the USD 334 million project would include a sales office, 'clinical trials, research and development and possibly manufacturing of vaccines'.

published on : 4th May 2021
1 2 >